Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01580267 · ClinicalTrials.gov registry record
Hepcidin and Anemia in Trauma
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 74
- Enrollment target
NCT01580267 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 74 participants.
The verdict
NCT01580267 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 74 participants
- Enrollment target
Study Summary
Anemia (decreased number of red blood cells) is common in critically ill trauma patients admitted to an Intensive Care Unit and is associated with a high rate of blood transfusions. This "anemia of inflammation" is a result of three mechanisms: impaired iron regulation, shortened red blood cell life span, and reduced rate of erythropoiesis (a protein that helps make new red blood cells). Hepcidin, a protein made in the liver, regulates iron and is decreased when iron in the blood is low. This can lead to anemia. This research study is being conducted to learn how inflammation, hepcidin, and erythropoietin interact in critically ill patients. The findings will help in determining effective treatment for patients with anemia of inflammation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2012-06 |
| Est. Completion | 2014-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01580267
The ClinicalTrials.gov registry entry for NCT01580267 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01580267 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01580267 about?
NCT01580267 is a clinical study titled "Hepcidin and Anemia in Trauma". Anemia (decreased number of red blood cells) is common in critically ill trauma patients admitted to an Intensive Care Unit and is associated with a high rate of blood transfusions. This "anemia of inflammation" is a result of three mechanisms: impaired iron regulation, shortened red blood cell life...
What is the current status of trial NCT01580267?
This trial is currently completed. The enrollment target is 74 participants. The study started on 2012-06. Estimated completion is 2014-04.
Who is sponsoring clinical trial NCT01580267?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.